|
| ||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 104 No. 6 December 1999, pp. 1400-1403
AMERICAN ACADEMY OF PEDIATRICS:
Human Immunodeficiency Virus and Other Blood-borne Viral
Pathogens in the Athletic Setting
| |
ABSTRACT |
|---|
|
|
|---|
Because athletes and the staff of athletic programs can be exposed to blood during athletic activity, they have a very small risk of becoming infected with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus. This statement, which updates a previous position statement of the American Academy of Pediatrics,1 discusses sports participation for athletes infected with these pathogens and the precautions needed to reduce the risk of infection to others in the athletic setting. Each of the recommendations in this statement is dependent upon and intended to be considered with reference to the other recommendations in this statement and not in isolation.
During sports participation, the blood of an athlete who is
infected with human immunodeficiency virus (HIV), hepatitis B virus
(HBV), or hepatitis C virus (HCV) may occasionally contaminate the skin
or mucous membranes of other athletes or the staff of athletic
programs. Common sense suggests that this likelihood is greatest in
contact sports, but transmission can potentially occur indirectly or in
noncontact sports. Even in contact sports, the very limited available
data indicate that bleeding wounds are not necessarily
common.2
The risk of HIV infection via skin or mucous membrane exposure to
blood or other infectious bodily fluids during sports participation is
very low. The most relevant research has been conducted with health
care workers, for whom the risk from skin or mucous membrane exposure
is less than the risk from parenteral exposure, which is .2% to
.3% per exposure (95% confidence interval [CI],
.1%-.5%).3 The risk from exposure to mucous membranes
or damaged skin determined from pooling 6 prospective studies was 1 infection in 1007 exposures, or .1% (95% CI, .01%-.5%). Such
transmission appears to require, in addition to a portal of entry,
prolonged exposure to large quantities of blood.3
Transmission through intact skin has not been documented: no HIV
infections occurred after 2712 such exposures in 1 large prospective
study (95% CI, 0%-.1%).3 Transmission of HIV in sports
has not been documented. One unsubstantiated report describes possible
transmission during a collision between professional soccer
players.4
The HBV is more easily transmitted via exposure to infected blood
than is HIV.3 In 2 studies of health care professionals who had percutaneous exposure to HBV-infected blood, the risk of
infection was 27% and 45%; approximately 25% of cases were symptomatic. The risk of infection was greater if the blood was positive for HBV e antigen. The health care workers received immune serum globulin, and so some of them were protected from
infection.5,6 Transmission of infection by contamination
of mucous membranes or broken skin with infected blood has been
documented, but the magnitude of risk has not been
quantified.3
Although transmission of HBV is apparently rare in sports, 2 reports
document such transmission. An asymptomatic high school sumo wrestler
who had a chronic infection transmitted HBV to other members of his
team.7 An epidemic of HBV infection occurred through
unknown means among Swedish athletes participating in track finding
(orienteering).8 The epidemiologists concluded that the
most likely route of infection was the use of water contaminated with
infected blood to clean wounds caused by branches and thorns.
An effective way of preventing HBV transmission in the athletic setting
is through immunization of athletes. The American Academy of Pediatrics
(AAP) recommends that all children and adolescents be
immunized.9 Clinicians and the staff of athletic programs should aggressively promote immunization.
Although the transmission risks of HCV infection are not
completely understood, the risk of infection from percutaneous exposure to infected blood is estimated to be 10 times greater than that of HIV
but lower than that of HBV.3 Transmission via contamination of mucous membranes or broken skin also probably has a
risk intermediate between that for blood infected with HIV and
HBV.3
Because of the very low probability of transmission of their
infection to other athletes, athletes infected with HIV, HBV, or HCV
should be allowed to participate in all sports.
Confidentiality about an athlete's infection with a blood-borne
pathogen is necessary to prevent exclusion of the athlete from sports
because of inappropriate fear among others in the program. Except for
the reporting required by law, the patient (and parent or guardian if
the patient is a minor) must give informed consent for clinicians to
share information about these medical conditions with a school or
sports organization. Testing of athletes for these viral infections is
not indicated. Infected athletes should be told that they have a very
small risk of infecting other competitors. This risk, although unknown
for any sport, is probably greatest in wrestling and boxing. Infected
athletes can be encouraged not to participate in these activities or in
others in which contamination of skin or mucous membranes with blood is
relatively likely. This may also be protective for infected athletes
themselves, reducing their possible exposure to blood-borne pathogens
other than the one(s) with which they are infected.
The AAP opposes boxing as a sport for youth. Pediatricians should
counsel athletes not to participate in this sport, whatever their
infection status.
Athletic programs should inform athletes and parents that athletes have
a very small but finite risk of contracting a blood-borne infection
from another athlete. This is part of the duty to warn about risks of
participation that is the responsibility of all athletic programs.
Pediatricians can avoid reporting the presence of infections with
blood-borne pathogens by making it clear on the preparticipation form
or elsewhere that they support the AAP policy, "Human
Immunodeficiency Virus and Other Blood-borne Pathogens in the Athletic
Setting," and that the AAP policy acknowledges that the physician
should respect the right of infected athletes to confidentiality.
The US Supreme Court has not ruled specifically on the legality of
excluding from competition an athlete who has a chronic infection with
a blood-borne viral pathogen but has held that a person infected with
a contagious disease may be handicapped and therefore entitled to
protection from unlawful discrimination. On the basis of this
authority, when considering whether an athlete infected with a
blood-borne viral pathogen can be excluded from competition, an
inquiry would have to be made "based on reasonable medical judgements
given the state of medical knowledge" into whether the athlete poses
a significant risk of communicating the disease to others in the
competition that cannot be eliminated by reasonable
accommodation.10,11
Strict safety precautions are particularly important for those
persons in athletic programs who provide first aid and have repeated
exposure to blood or other bodily fluids visibly contaminated with
blood. Specific precautions are discussed in Recommendation 10 below.
Other discussions of safety precautions appropriate for sports
programs, with some additional information, are available elsewhere.1012-14
Coaches, athletic trainers, and health care professionals can
expand discussions about the risks of transmission of blood-borne viral pathogens during sports participation to teach athletes about how
these pathogens are transmitted and how to prevent infection.
![]()
HIV INFECTION
![]()
HBV INFECTION
![]()
HCV INFECTION
![]()
SUMMARY
Top
Abstract
Conclusion
Recommendation
References
![]()
CONFIDENTIALITY AND OTHER LEGAL ISSUES
![]()
PREVENTION OF INFECTION
![]()
EDUCATION OF ATHLETES
![]()
RECOMMENDATIONS
Top
Abstract
Conclusion
Recommendation
References
COMMITTEE ON SPORTS MEDICINE AND FITNESS,
1999-2000
Steven J. Anderson, MD, Chairperson
Bernard A. Griesemer, MD
Miriam D. Johnson, MD
Thomas J. Martin, MD
Larry G. McLain, MD
Thomas W. Rowland, MD
Eric Small, MD
LIAISON REPRESENTATIVES
Claire LeBlanc, MD
Canadian Paediatric Society
Carl Krein, AT, PT
National Athletic Trainers Association
Robert Malina, PhD
Institute for the Study of Youth Sports
Judith C. Young, PhD
National Association for Sport and Physical Education
SECTION LIAISONS
Frederick E. Reed, MD
Section on Orthopaedics
Reginald L. Washington, MD
Section on Cardiology
CONSULTANT
William L. Risser, MD, PhD
| |
FOOTNOTES |
|---|
The recommendations in this statement are based upon present available knowledge. They do not indicate an exclusive course of treatment or serve as a standard of medical care. Laws vary from state to state and state law may dictate a different course of action for the physician or those in charge of an athletic program. Variations, taking into account individual circumstances, may also be appropriate.
| |
ABBREVIATIONS |
|---|
HIV, human immunodeficiency virus; HBV, hepatitis B virus; HCV, hepatitis C virus; CI, 95% confidence interval; AAP, American Academy of Pediatrics; OSHA, Occupational Safety and Health Administration.
| |
REFERENCES |
|---|
|
|
|---|
-
American Academy of Pediatrics
Human immunodeficiency virus [acquired immunodeficiency syndrome (AIDS) virus] in the athletic setting.
Pediatrics.
1991;
88:640-641
[Abstract/Free Full Text] -
Brown LS Jr,
Drotman P,
Chu A,
Brown CLJ,
Knowlan D
Bleeding injuries in professional football: estimating the risk for HIV transmission.
Ann Intern Med.
1995;
122:271-274
[Abstract/Free Full Text] -
Gerberding JL
Management of occupational exposures to blood-borne viruses.
N Engl J Med.
1995;
332:444-451
[Free Full Text] - Torre D, Sampietro C, Ferraro G, Zeroli C, Speranza F Transmission of HIV-1 infection via sports injury. Lancet. 1990; 335:1105 [Medline]
- Seeff LB, Wright EC, Zimmerman HJ, Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin, final report of the Veterans Administration cooperative study. Ann Intern Med. 1978; 88:285-293
- Grady, GF, Lee VA, Prince AM, et al Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978; 138:625-638 [Medline]
-
Kashiwagi S,
Hayashi J,
Ikematsu H,
An outbreak of hepatitis B in members of a high school sumo wrestling club.
JAMA.
1982;
248:213-214
[Abstract/Free Full Text] - Ringertz O, Zetterberg B Serum hepatitis among Swedish track finders: an epidemiologic study. N Engl J Med. 1967; 276:540-546
- American Academy of Pediatrics. In: Pickering LK, ed. 2000 Red Book. Report of the Committee on Infectious Diseases. 25th ed, Elk Grove Village, IL: American Academy of Pediatrics. In press
- American Medical Society for Sports Medicine and the American Academy of Sports Medicine Human immunodeficiency virus and other blood-borne pathogens in sports. Clin J Sport Med. 1995; 5:199-204 [Medline]
- Mitten MJ Athletic participation with a contagious blood-borne disease. Clin J Sport Med. 1995; 5:153-154 [Medline]
- Centers for Disease Control and Prevention Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep. 1989; 38:1-37
- American Academy of Pediatrics. OSHA. Materials to Assist the Pediatric Office in Implementing the Bloodborne Pathogen, Hazard Communication, and Other OSHA Standards. 2nd ed. Elk Grove Village, IL: American Academy of Pediatrics; 1994
-
Mast EE,
Goodman RA,
Bond WW,
Favero MS,
Drotman DP
Transmission of blood-borne pathogens during sports: risk and prevention.
Ann Intern Med.
1995;
122:283-285
[Abstract/Free Full Text]
Pediatrics (ISSN 0031 4005). Copyright ©1999 by the American Academy of Pediatrics
Statements of reaffirmation:
-
AAP Publications Retired and Reaffirmed
Pediatrics 2009 123: 188.[Extract] [Full Text] [PDF]
-
AAP Publications Retired and Reaffirmed
Pediatrics 2009 123: 1421-1422.[Extract] [Full Text] [PDF]
The following policy statement has been revised:
- Human Immunodeficiency Virus [Acquired Immunodeficiency Syndrome(AIDS) Virus] in the Athletic Setting
- Committee on Sports Medicine and Fitness
Pediatrics 1991 88: 640-641.[Abstract] [PDF]
This article has been cited by other articles:
![]() |
Infections Spread by Blood and Body Fluids Red Book, January 1, 2009; 2009(1): 146 - 148. [Full Text] |
||||
![]() |
S. G. Rice and and the Council on Sports Medicine and Fitness Medical Conditions Affecting Sports Participation Pediatrics, April 1, 2008; 121(4): 841 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
Infections Spread by Blood and Body Fluids Red Book, January 1, 2006; 2006(1): 151 - 153. [Full Text] |
||||
![]() |
C. Kukka Bloodborne Infections: Should They Be Disclosed? Is Differential Treatment Necessary? The Journal of School Nursing, December 1, 2004; 20(6): 324 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Kordi, W A Wallace, and J Orchard Blood borne infections in sport: risks of transmission, methods of prevention, and recommendations for hepatitis B vaccination * Commentary Br. J. Sports Med., December 1, 2004; 38(6): 678 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
School Health Red Book, January 1, 2003; 2003(1): 137 - 146. [Full Text] |
||||
![]() |
Committee on Pediatric AIDS and Committee on Adole Adolescents and Human Immunodeficiency Virus Infection: The Role of the Pediatrician in Prevention and Intervention Pediatrics, January 1, 2001; 107(1): 188 - 190. [Abstract] [Full Text] |
||||
![]() |
Committee on Pediatric AIDS Education of Children With Human Immunodeficiency Virus Infection Pediatrics, June 1, 2000; 105(6): 1358 - 1360. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||





